Skip to main content
Clinical Trials/ACTRN12605000528651
ACTRN12605000528651
Completed
Phase 1

A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism

Acrux DDS Pty Ltd0 sites12 target enrollmentSeptember 26, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hypogonadism
Sponsor
Acrux DDS Pty Ltd
Enrollment
12
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials